查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497634

BETA干擾素市場：按類型、給藥途徑、應用和分銷管道分類 - 2024-2030 年全球預測

Beta Interferon Market by Type (Interferon Beta-1A, Interferon Beta-1B), Route of Administration (Intramuscular, Intravenous, Subcutaneous), Application, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年BETA干擾素市場規模為34.4億美元，預計2024年將達36.2億美元，2030年將達51.1億美元，複合年成長率為5.83%。

BETA干擾素是一種天然存在於人體內的蛋白質，在免疫系統抵抗感染疾病和疾病方面發揮重要作用。它們被歸類為細胞激素，是免疫系統廣泛用於細胞間通訊的一組訊號蛋白的一部分。用於治療多發性硬化症（MS），一種使人衰弱的神經系統疾病。 BETA干擾素可減少發炎和復發頻率，並改善多發性硬化症患者的病程。全球診斷出多發性硬化症的患者數量不斷增加，對有效治療方案的需求正在推動市場發展。此外，旨在傳播多發性硬化症及其治療方案知識的宣傳計劃和全球健康舉措正在刺激市場需求。然而，與BETA干擾素相關的副作用，例如類流感症狀、部位反應和潛在的肝損傷，可能會阻止一些患者選擇這種治療。此外，旨在提高BETA-干擾素製劑的功效並減少副作用的持續研究和開發對公司來說是一個充滿希望的機會。開拓多發性硬化症以外的新治療應用，並擴展到醫療需求未滿足的新興國家，是BETA干擾素市場相關人員的重要成長槓桿。

主要市場統計
基準年[2023] 34.4億美元
預測年份 [2024] 36.2億美元
預測年份 [2030] 51.1億美元
複合年成長率（%） 5.83%

區域洞察

在美洲，特別是在美國和加拿大，多發性硬化症盛行率的上升以及患者尋求有效且安全的治療方法來控制症狀和減緩疾病進展正在推動BETA干擾素市場的發展。該地區最近的專利集中在改進BETA-干擾素配方，透過減少劑量次數來提高患者的依從性。還有對個人化醫療的投資，試圖根據個人的基因組成客製化治療方法，這可以提高BETA-干擾素治療的有效性。同時，歐洲、中東和非洲市場多元化，各國的報銷政策差異很大，但整體而言有利於多發性硬化症治療。歐洲藥品管理局 (EMA) 積極核准創新的給藥方案和配方，以確保更好的結果並提高患者的依從性。該地區的一項新專利旨在減少與BETA干擾素相關的副作用，從而提高患者的生活品質。在亞太地區，BETA干擾素市場正穩定成長。這一趨勢在很大程度上是由於人們對多發性硬化症及其症狀的認知不斷提高以及改善治療機會的綜合醫療保健政策所推動的。中國、日本和澳洲等國家憑藉其先進的醫療保健系統和不斷增加的醫學研究投資，在該區域市場中佔據重要地位。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在 Beta干擾素市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對 Beta干擾素市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在BETA干擾素市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中自體免疫疾病盛行率上升
      • 提高免疫疾病的醫療保健意識和努力
      • 改善國家醫療基礎設施和支出
    • 抑制因素
      • 部分醫療案例BETA干擾素效率低、高成本的問題
    • 機會
      • 為多發性硬化症患者進行先進個人化疾病管理的強大研究工作
      • 開發技術主導的疾病診斷平台
    • 任務
      • 與 BETA干擾素產品相關的嚴格且漫長的核准流程
  • 市場區隔分析
    • 類型：在多發性硬化症病例中根據需要使用BETA型干擾素 1A 和 BETA 1B
    • 應用：增加BETA干擾素在治療免疫感染疾病的應用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 BETA干擾素市場：依類型

  • BETA型干擾素BETA1A
  • BETA型干擾素BETA1B

第7章 BETA干擾素市場：依給藥途徑

  • 肌肉注射
  • 靜脈
  • 皮下的

第8章 BETA干擾素市場：依應用分類

  • 抗病毒作用
  • 免疫調節作用

第 9 章 BETA干擾素市場：按通路

  • 醫院藥房
  • 網路藥房

第10章 美洲BETA干擾素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區BETA干擾素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲BETA-干擾素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • 羅氏製藥印度公司宣布推出治療多發性硬化症的新型單株抗體“Ocrevus”
    • Nona Bioscience 與 Boost Immune 結成策略聯盟，加速癌症治療創新
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-521BAA36EA1C

[195 Pages Report] The Beta Interferon Market size was estimated at USD 3.44 billion in 2023 and expected to reach USD 3.62 billion in 2024, at a CAGR 5.83% to reach USD 5.11 billion by 2030.

Beta interferon is a type of protein that naturally occurs in the human body and plays an important role in the immune system, to fight off infections and diseases. It is classified as a cytokine, which means it is part of the signaling proteins widely used by the immune system to communicate between cells. It is used in the treatment of multiple sclerosis (MS), a debilitating neurological condition. Beta Interferon helps reduce inflammation and the frequency of relapses in MS patients, thereby modifying the disease course. The rising number of diagnosed MS cases globally drives demand for effective treatment options, boosting the market. In addition, awareness programs and global health initiatives to spread knowledge about multiple sclerosis and its treatment options stimulate market demand. However, the side effects associated with beta interferon, such as flu-like symptoms, site reactions, and potential liver damage, may deter some patients from opting for this treatment. Moreover, ongoing research and development activities aimed at enhancing the efficacy and lowering the adverse effects of beta interferon preparations present promising opportunities for companies. Exploring novel therapeutic applications beyond multiple sclerosis and expanding into emerging economies with unmet medical needs present significant growth avenues for stakeholders in the beta interferon market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.44 billion
Estimated Year [2024] USD 3.62 billion
Forecast Year [2030] USD 5.11 billion
CAGR (%) 5.83%

Regional Insights

In the Americas, particularly in the United States and Canada, the beta interferon market is driven by the rising prevalence of MS, with patients seeking effective and safer therapies that can manage symptoms and delay disease progression. Recent patents in this region have focused on improvements in Beta Interferon formulations that enhance patient adherence by reducing the frequency of doses. Investments are also being channeled toward personalized medicine, which attempts to tailor treatments to the individual's genetic composition, potentially increasing the efficacy of beta-interferon therapies. At the same time, the EMEA market is diverse, with reimbursement policies varying significantly across countries, but they are generally favorable towards MS treatments. The European Medicines Agency (EMA) has proactively approved innovative dosing regimens and formulations that promise better outcomes or enhanced patient compliance. New patents in the region have aimed at reducing side effects associated with Beta Interferon, thereby improving the quality of life for patients. In the Asia Pacific region, the market for beta interferon is experiencing steady growth. This trend is largely driven by increasing awareness about MS and its symptoms, coupled with more comprehensive healthcare policies that are improving access to treatments. Countries such as China, Japan, and Australia are significant in the regional market due to their advanced healthcare systems and increasing investment in medical research.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Beta Interferon Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of autoimmune diseases among population
      • Growing healthcare awareness and initiatives for immune disorders
      • Improved healthcare infrastructure and spending across economies
    • Market Restraints
      • Issues associated with ineffectiveness and high costs of beta interferon for some medical cases
    • Market Opportunities
      • Robust research activities to advanced individualized disease management for people living with multiple sclerosis
      • Development of technology-driven platforms for disease diagnosis
    • Market Challenges
      • Stringent and time consuming approval processes associated with beta interferon products
  • Market Segmentation Analysis
    • Type: Utilization of interferon Beta-1A and Beta-1B as per their need in multiple sclerosis cases
    • Application: Increasing usage of beta interferon to treat immuno infectious diseases
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Beta Interferon Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Beta Interferon Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Roche Pharma India Introduces Ocrevus: A Novel Monoclonal Antibody for Multiple Sclerosis

Roche Pharma India, part of the global Swiss pharmaceutical conglomerate Roche, officially launched Ocrevus (ocrelizumab) in the Indian market, offering new hope to the 150,000-200,000 patients diagnosed with multiple sclerosis (MS) in the country. This biannual, two-hour infusion therapy marks a significant advancement over existing treatments by specifically targeting CD20+ B cells, which are implicated in the aggressive progression of MS by damaging the myelin sheath of nerve fibers. [Published On: 2024-02-27]

Strategic Collaboration between Nona Biosciences and Boostimmune to Accelerate Cancer Therapy Innovations

Nona Biosciences entered a collaboration with Boostimmune, a company focused on advanced anti-cancer therapies. This partnership aims to utilize Nona Biosciences' proprietary Harbour Mice H2L2 platform, which produces fully human monoclonal antibodies, to develop cutting-edge Antibody-Drug Conjugates (ADCs) aimed at novel cancer targets. With its extensive experience in antibody discovery and development, Nona Biosciences supports projects from conception to Investigational New Drug (IND) application, ensuring a comprehensive integration of services to foster significant advancements in cancer treatment. [Published On: 2024-02-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Beta Interferon Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Beta Interferon Market, highlighting leading vendors and their innovative profiles. These include Amega Biotech, Avantor, Inc., Bayer AG, Biogen Inc., BioLegend, Inc. by PerkinElmer Inc., Biosidus S.A, F. Hoffmann La-Roche Ltd., Faron Pharmaceuticals, Heligenics, Inc., Merck KGaA, Novartis AG, OriGene Technologies, Inc., Pfizer Inc., Qiagen GmbH, Sino Biological, Inc., Synairgen PLC, Thermo Fisher Scientific Inc., and Xiamen Amoytop Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Beta Interferon Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Interferon Beta-1A
    • Interferon Beta-1B
  • Route of Administration
    • Intramuscular
    • Intravenous
    • Subcutaneous
  • Application
    • Antiviral Effects
    • Immunomodulatory Effects
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of autoimmune diseases among population
      • 5.1.1.2. Growing healthcare awareness and initiatives for immune disorders
      • 5.1.1.3. Improved healthcare infrastructure and spending across economies
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with ineffectiveness and high costs of beta interferon for some medical cases
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust research activities to advanced individualized disease management for people living with multiple sclerosis
      • 5.1.3.2. Development of technology-driven platforms for disease diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time consuming approval processes associated with beta interferon products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of interferon Beta-1A and Beta-1B as per their need in multiple sclerosis cases
    • 5.2.2. Application: Increasing usage of beta interferon to treat immuno infectious diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Beta Interferon Market, by Type

  • 6.1. Introduction
  • 6.2. Interferon Beta-1A
  • 6.3. Interferon Beta-1B

7. Beta Interferon Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Intramuscular
  • 7.3. Intravenous
  • 7.4. Subcutaneous

8. Beta Interferon Market, by Application

  • 8.1. Introduction
  • 8.2. Antiviral Effects
  • 8.3. Immunomodulatory Effects

9. Beta Interferon Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies

10. Americas Beta Interferon Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Beta Interferon Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Beta Interferon Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Roche Pharma India Introduces Ocrevus: A Novel Monoclonal Antibody for Multiple Sclerosis
    • 13.3.2. Strategic Collaboration between Nona Biosciences and Boostimmune to Accelerate Cancer Therapy Innovations
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BETA INTERFERON MARKET RESEARCH PROCESS
  • FIGURE 2. BETA INTERFERON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BETA INTERFERON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BETA INTERFERON MARKET DYNAMICS
  • FIGURE 7. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BETA INTERFERON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. BETA INTERFERON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BETA INTERFERON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BETA INTERFERON MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BETA INTERFERON MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BETA INTERFERON MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1A, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1A, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1B, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BETA INTERFERON MARKET SIZE, BY INTERFERON BETA-1B, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BETA INTERFERON MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BETA INTERFERON MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BETA INTERFERON MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BETA INTERFERON MARKET SIZE, BY ANTIVIRAL EFFECTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BETA INTERFERON MARKET SIZE, BY ANTIVIRAL EFFECTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BETA INTERFERON MARKET SIZE, BY IMMUNOMODULATORY EFFECTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BETA INTERFERON MARKET SIZE, BY IMMUNOMODULATORY EFFECTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BETA INTERFERON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BETA INTERFERON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BETA INTERFERON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BETA INTERFERON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES BETA INTERFERON MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 119. INDONESIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. INDONESIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. JAPAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. JAPAN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. MALAYSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MALAYSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. PHILIPPINES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. SINGAPORE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. SINGAPORE BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. TAIWAN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. TAIWAN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. THAILAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. THAILAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. VIETNAM BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. VIETNAM BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BETA INTERFERON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 201. DENMARK BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. DENMARK BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 209. EGYPT BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. EGYPT BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. FINLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. FINLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. FRANCE BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. FRANCE BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. GERMANY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. GERMANY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. ISRAEL BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. ISRAEL BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. ITALY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. ITALY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. NETHERLANDS BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 265. NIGERIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. NIGERIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. NORWAY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NORWAY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. POLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. POLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. QATAR BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. QATAR BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. RUSSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. RUSSIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 321. SPAIN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SPAIN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 329. SWEDEN BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SWEDEN BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SWITZERLAND BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 345. TURKEY BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. TURKEY BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY BETA INTERFERON MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY BETA INTERFERON MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY BETA INTERFERON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES BETA INTERFERON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES BETA INTER